Area of research
Physiology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Medicine, Asthma, COPD, Internal medicine, Formoterol, and Intensive care medicine.
Impact of Smoking on Biological Treatment Response in Patients From the German Severe Asthma (GAN) Registry
German Asthma Net: Characterisation of responders to anti-IL-5 and anti-IL-5(R) therapy
Clinical and Economic Burden of COPD in Patients on Inhaled Triple Therapy in Germany – A Retrospective Claims Data Analysis
Poor Rhinitis and Asthma Control Is Associated With Decreased Health-Related Quality of Life and Utilities: A MASK-air Study
Obituary: Professor Marcus Maurer, Berlin, Germany
Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study
Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The <scp>ARIA‐EAACI</scp> approach – ARIA‐EAACI Task Force Report
Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study
Global access and patient safety in the transition to environmentally friendly respiratory inhalers: the Global Initiative for Asthma perspective
Asthma Prevalence and Phenotyping in the General Population: The LEAD (Lung, hEart, sociAl, boDy) Study
Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study
In ‘real world’ patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbations
Erratum: S2k-Leitlinie zur fachärztlichen Diagnostik und Therapie von Asthma 2023
European Respiratory Society guidelines for the diagnosis of asthma in adults
Disease-modifying anti-asthmatic drugs
Safety of combining biologics in severe asthma: Asthma‐related and unrelated combinations
The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control
Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease: results from COSYCONET
Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app
Fraction of exhaled nitric oxide is associated with disease burden in the German Asthma Net severe asthma cohort
Is Inhaler Technique Adequately Assessed and Reported in Clinical Trials of Asthma and Chronic Obstructive Pulmonary Disease Therapy? A Systematic Review and Suggested Best Practice Checklist
Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: A Retrospective German Claims Data Analysis
Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD ‘real world’ study
Costs and Clinical Consequences of Compliance with COPD GOLD Recommendations or National Guidelines Compared with Current Clinical Practice in Belgium, Germany, Sweden, and the United States
Development and Validation of an Electronic Daily Control Score for Asthma (e-DASTHMA)
Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes
Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes
[Guideline for the Diagnosis and Treatment of Asthma - Addendum 2020 - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology].